Skip to content
×
Register

2019 Diabetic Lower Extremity Symposium

The Rongxiang Xu, MD, Center for Regenerative Therapeutics at  Beth Israel Deaconess Medical Center and the Wyss Institute at Harvard  University present: The Diabetic Lower Extremity Symposium: From  Innovation to Therapy

November 7-8, 2019

Rotunda, Joseph B. Martin Conference Center

77 Avenue Louis Pasteur
Boston, MA 02115
4464d118f548432fb0c3d33d418e2208

This meeting will focus on the management of diabetic lower extremity and other chronic wounds. The meeting will include top experts from all over the world and will facilitate interaction between small and big pharma and academicians.

781e5f4c27a34da18ce7da0a6c74035f

What is this meeting about? 

Diabetic foot problems significantly impair the quality of life of diabetic patients. Each year in the United States, these complications lead to more than 750,000 new diabetic foot ulcers and 70,000 lower extremity amputations. This extraordinary one and a half day symposium will promote better understanding of the unmet management needs of Diabetic Lower Extremity (DLE) complications and the new therapeutic approaches that are currently under development.

Day
Hour
Minute
Second

Main objectives:

  • Provide an overview of current and unmet management of DLE complications caused by reduced blood supply and/or neuropathic damage
  • Discuss new developments in basic, translational and biomaterial research that impact DLE management
  • Explore new therapeutic approaches, from early pre-clinical to late clinical stage of development through presentations from leaders in academia and in the biotechnology industry
  • Identify possible areas of collaboration between academia and industry

Who should attend this symposium?

  • Physicians involved in DLE management (general, vascular and plastic surgeons, podiatrists, diabetologists, ID specialists, neurologists, wound care specialists)
  • Scientists and engineers involved in fundamental or translational biomaterial research
  • R&D personnel from small and large pharmaceutical and biotechnology companies involved in the development of new therapeutic approaches for DLE
7ad841f193b7464ca1cce8d4ed2f0a33
  • Physician........................................$199
  • RN/Staff............................................$50
  • Fellow/Resident/Student.................Free
Contact Us
Register Online